Vipul Amin, MD
Gastroenterology · Gadsden, ALNPI 1720070659
Payments from drug & device makers
Across 62 payments — averaging $72.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Braintree Laboratories, Inc.$728
- Gilead$117
- Ironwood Pharmaceuticals, Inc$48
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$43
- Takeda Pharmaceuticals U.S.A., Inc.$40
- plus $147 from 7 others
What the payments were for
- Speaking & faculty fees$3,20071%
- Food & beverage$59313%
- Education$90%
- Gifts$69415%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 23 | $3,373 |
| Braintree Laboratories, Inc. | 16 | $728 |
| Gilead | 7 | $117 |
| Ironwood Pharmaceuticals, Inc | 4 | $48 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $43 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $40 |
| QOL Medical, LLC | 1 | $34 |
| Ardelyx, Inc. | 1 | $24 |
| Phathom Pharmaceuticals, Inc. | 1 | $23 |
| Johnson & Johnson | 1 | $21 |
| Ferring Pharmaceuticals Inc. | 1 | $16 |
| Conmed Corporation | 1 | $15 |
| Regeneron Healthcare Solutions, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,496 in reported general payments places this provider in the 55th percentile of 225 gastroenterology providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EpclusaSofosbuvir/Velpatasvir | 15 | $365,338 |
| LinzessLinaclotide | 148 | $96,672 |
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 614 | $38,430 |
| TrulancePlecanatide | 26 | $21,096 |
| Mesalamine | 29 | $18,904 |
| ZenpepLipase/Protease/Amylase | 12 | $16,648 |
| CholestyramineCholestyramine (With Sugar) | 58 | $3,930 |
| Pantoprazole Sodium | 488 | $3,572 |
| SutabSod Sulf/Pot Chloride/Mag Sulf | 22 | $3,500 |
| Mesalamine ErMesalamine | 12 | $1,644 |
| Balsalazide Disodium | 12 | $1,625 |
| SuflavePeg 3350/Sod Sulf,chlr/Pot/Mag | 11 | $1,336 |
| Famotidine | 97 | $1,192 |
| Diphenoxylate-AtropineDiphenoxylate Hcl/Atropine | 45 | $785 |
| Esomeprazole Magnesium | 21 | $702 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GileadEpclusa | $117 | $365,33815 claims |
| AbbVieLinzess | $3,373 | $96,672148 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCTrulance | $43 | $21,09626 claims |
| Braintree Laboratories, Inc.Sutab, Suflave | $728 | $4,83633 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 225 gastroenterology providers in Alabama.
Other gastroenterology in Gadsden
- Jonathan SiegelMobile$2.6M
- Michael BrownDecatur$1.7M
- Paul LambDothan$1.2M
- Robert ShafferBirmingham$1.2M
- Charles JohnsonMobile$1.2M
- Jack DipalmaMobile$958K
- William McLaughlinDothan$745K
- Charles DasherHomewood$666K
- Samuel TarwaterDothan$664K
- Meagan GrayBirmingham$600K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.